PREDICTION OF CHEMOTHERAPY INDUCED CARDIOMYOPATHY WITH MRI DETECT I
用 MRI Detect I 预测化疗引起的心肌病
基本信息
- 批准号:8167008
- 负责人:
- 金额:$ 5.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdultCancer PatientCardiacCardiomyopathiesCardiotoxicityCardiovascular systemChildComputer Retrieval of Information on Scientific Projects DatabaseCongestive Heart FailureCyclophosphamideDataDeteriorationDoxorubicinFundingGrantInstitutionLeftLeft Ventricular Ejection FractionMagnetic Resonance ImagingMalignant NeoplasmsMeasuresMyocardial perfusionPaclitaxelPatientsRelaxationResearchResearch PersonnelResourcesRoche brand of trastuzumabSourceTreatment-Related CancerTumor BurdenUnited States National Institutes of HealthVentricularchemotherapyfalls
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Doxorubicin prolongs survival and reduces tumor burden for many children and adults with cancer, but its use can cause irreversible congestive heart failure (CHF). Herceptin, Paclitaxel and Cyclophosphamide are also agents that are widely used for treatment of cancer and are associated with cardiotoxicity. Although a fall in left ventricular ejection (LVEF) detected during the course of chemotherapy may forecast the onset of CHF, it may occur only after irreversible cardiac damage has been sustained.
Recently, cardiovascular magnetic resonance imaging (MRI) has been used to quantify
regional changes in left ventricular diastolic regional relaxation. Studies in children have
documented alterations in LV diastolic function in patients receiving Doxorubicin therapy often
precede a deterioration in left ventricular ejection fraction. Pilot data generated from our
institution indicates that MRI can be used to detect abnormalities of left ventricular relaxation in
patients with varying degrees of LVEF. It is our intent to identify the association between cardiotoxicity and reductions in left ventricular diastolic relaxation or myocardial perfusion measured with MRI in cancer patients receiving chemotherapy.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
阿霉素会延长生存率并减轻许多患有癌症的儿童和成人的肿瘤负担,但其使用可能会导致不可逆的充血性心力衰竭(CHF)。赫赛汀,紫杉醇和环磷酰胺也是广泛用于癌症的药物,与心脏毒性有关。 尽管在化学疗法过程中检测到的左心室射血(LVEF)可能会预测CHF的发作,但它可能仅在无法可逆的心脏损伤持续后才发生。
最近,心血管磁共振成像(MRI)已用于量化
左心室舒张性区域放松的区域变化。 对儿童的研究有
经常接受阿霉素疗法的患者的LV舒张功能的变化
在左心室射血分数中的恶化之前。 从我们的飞行员数据
机构表示,MRI可用于检测左心室放松异常
LVEF程度不同的患者。 我们的目的是确定心脏毒性与左心室舒张压弛豫的降低或在接受化学疗法的癌症患者中测量的MRI的心肌灌注之间的关联。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Gregory Hundley其他文献
William Gregory Hundley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Gregory Hundley', 18)}}的其他基金
Multi-Disciplinary Training Program in Translational Cardiovascular Research
转化心血管研究的多学科培训计划
- 批准号:
10583494 - 财政年份:2020
- 资助金额:
$ 5.88万 - 项目类别:
Multi-Disciplinary Training Program in Translational Cardiovascular Research
转化心血管研究的多学科培训计划
- 批准号:
10369689 - 财政年份:2020
- 资助金额:
$ 5.88万 - 项目类别:
Multi-Disciplinary Training Program in Translational Cardiovascular Research
转化心血管研究的多学科培训计划
- 批准号:
10117092 - 财政年份:2020
- 资助金额:
$ 5.88万 - 项目类别:
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment
通过针对接受治疗的淋巴瘤患者进行量身定制的身体活动干预来提高运动能力
- 批准号:
10705825 - 财政年份:2018
- 资助金额:
$ 5.88万 - 项目类别:
Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment
通过针对接受治疗的淋巴瘤患者进行量身定制的身体活动干预来提高运动能力
- 批准号:
10701107 - 财政年份:2018
- 资助金额:
$ 5.88万 - 项目类别:
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment
了解和预测疲劳、CV 下降
- 批准号:
9994850 - 财政年份:2015
- 资助金额:
$ 5.88万 - 项目类别:
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment
了解和预测疲劳、CV 下降
- 批准号:
9124809 - 财政年份:2015
- 资助金额:
$ 5.88万 - 项目类别:
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment
了解和预测疲劳、CV 下降
- 批准号:
10481826 - 财政年份:2015
- 资助金额:
$ 5.88万 - 项目类别:
相似国自然基金
基于生命质量的癌症患者心理行为与护理干预
- 批准号:72381240026
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:国际(地区)合作与交流项目
关键意见领袖双主体协同导航的癌症患者数智旅程管理模式研究
- 批准号:72374048
- 批准年份:2023
- 资助金额:40.00 万元
- 项目类别:面上项目
基于哈佛癌症指数构建老年骨科大手术患者静脉血栓栓塞症风险预警系统及干预策略研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于哈佛癌症指数构建老年骨科大手术患者静脉血栓栓塞症风险预警系统及干预策略研究
- 批准号:72204268
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
青年癌症患者心理痛苦变化轨迹预测及健康教练技术干预研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
- 批准号:
10678157 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
Individualized medicine to predict and prevent chemotherapy-related heart failure
预测和预防化疗相关心力衰竭的个体化药物
- 批准号:
10714111 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer Survivors
基于机器学习的儿童癌症幸存者心肌病风险识别
- 批准号:
10730177 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
The Clinical Relevance of Anthracycline-Related Cardiac Remodeling in Childhood Cancer Survivors
儿童癌症幸存者中蒽环类药物相关心脏重塑的临床意义
- 批准号:
10740728 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别: